Todd brings over 20 years of healthcare investment experience as a sell side analyst, LP,
and buy side investor to co-lead our Growth team. As a student, Todd worked
part-time in his father’s pharmaceutical warehouse, which inspired him to
pursue a career in the healthcare industry. His greatest passion is working
with entrepreneurs to bring transformative products to market.

He sits
on the boards of Biolojic Design, MOBILion, Scipher Medicine, Theranica, and
Ultima Genomics. Before joining aMoon, Todd was a Managing Director at Signet
Healthcare Partners, an investment fund that provides growth capital to
commercial-stage life-science companies. He co-led the investment in Claris
Lifesciences (sold to Baxter), and served on the boards of Arbor
Pharmaceuticals (sold to KKR), Apicore (sold to Medicure), and Smart Medical
Systems.

Prior to
Signet, Todd served as an Investment Director at Joddes, a family office with
interests in numerous lifescience companies, including Pharmascience, Medicom
and Paladin Labs. Earlier in his career, Todd was an equity analyst at Morgan
Stanley and Goldman Sachs in New York, covering the US pharmaceutical sector.
He started his career as a strategy consultant with Mercer Management
Consulting.

He received a Bachelor of Commerce with High Distinction from the University of
Toronto, and an MBA from The Wharton School at the University of Pennsylvania
with concentrations in healthcare management and finance